908 DEVICES INC. Operating Cash Flow
908 DEVICES INC. (MASS) reported Operating Cash Flow of $4.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- 908 DEVICES INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $3.17M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $1.21M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $1.32M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.20M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for fiscal 2025 was -$23.69M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for fiscal 2024 was -$30.25M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for fiscal 2023 was -$25.06M.
- 908 DEVICES INC. net cash provided by (used in) operating activities for fiscal 2022 was -$20.93M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $4.38M 10-Q · filed 2026-08-11 | $5.70M derived: sum of 3 quarters · filed 2026-08-11 | $1.49M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-06 | $2.52M derived: sum of 2 quarters · filed 2026-05-06 | -$1.68M derived: sum of 3 quarters · filed 2026-05-06 | -$7.46M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$2.88M derived: sum of 2 quarters · filed 2026-03-09 | -$8.67M derived: sum of 3 quarters · filed 2026-08-11 | -$23.69M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$9.99M derived: sum of 2 quarters · filed 2026-08-11 | -$25.01M 10-Q · filed 2025-11-10 | -$27.25M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$20.80M 10-Q · filed 2026-08-11 | -$23.05M derived: sum of 3 quarters · filed 2026-08-11 | -$28.65M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$15.02M 10-Q · filed 2026-05-06 | -$17.26M derived: sum of 2 quarters · filed 2026-05-06 | -$22.87M derived: sum of 3 quarters · filed 2026-05-06 | -$35.91M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$7.85M derived: sum of 2 quarters · filed 2026-03-09 | -$20.89M derived: sum of 3 quarters · filed 2026-03-09 | -$30.25M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$5.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$18.65M derived: sum of 2 quarters · filed 2025-11-10 | -$28.00M 10-Q · filed 2025-11-10 | -$29.93M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$13.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$22.40M 10-Q · filed 2025-08-05 | -$24.33M derived: sum of 3 quarters · filed 2025-08-05 | -$28.93M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$9.36M 10-Q · filed 2025-05-13 | -$11.29M derived: sum of 2 quarters · filed 2025-05-13 | -$15.89M derived: sum of 3 quarters · filed 2025-05-13 | -$23.77M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$6.53M derived: sum of 2 quarters · filed 2025-03-07 | -$14.41M derived: sum of 3 quarters · filed 2025-03-07 | -$25.06M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$4.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$12.48M derived: sum of 2 quarters · filed 2024-11-12 | -$23.13M 10-Q · filed 2024-11-12 | -$28.25M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$7.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$18.53M 10-Q · filed 2024-08-06 | -$23.64M derived: sum of 3 quarters · filed 2024-08-06 | -$28.58M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$10.65M 10-Q · filed 2024-05-03 | -$15.76M derived: sum of 2 quarters · filed 2024-05-03 | -$20.70M derived: sum of 3 quarters · filed 2024-05-03 | -$31.11M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$10.05M derived: sum of 2 quarters · filed 2024-03-08 | -$20.46M derived: sum of 3 quarters · filed 2024-03-08 | -$20.93M 10-K · filed 2024-03-08 |
| 2022-09-30 | -$4.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$15.35M derived: sum of 2 quarters · filed 2023-11-07 | -$15.81M 10-Q · filed 2023-11-07 | -$25.03M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$10.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$10.88M 10-Q · filed 2023-08-08 | -$20.10M derived: sum of 3 quarters · filed 2023-08-08 | -$23.02M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$466.00K 10-Q · filed 2023-05-09 | -$9.69M derived: sum of 2 quarters · filed 2023-05-09 | -$12.61M derived: sum of 3 quarters · filed 2023-05-09 | -$19.91M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$9.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$12.14M derived: sum of 2 quarters · filed 2023-03-15 | -$19.45M derived: sum of 3 quarters · filed 2023-03-15 | -$29.08M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$10.23M derived: sum of 2 quarters · filed 2022-11-14 | -$19.86M 10-Q · filed 2022-11-14 | -$17.53M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$16.94M 10-Q · filed 2022-08-09 | -$14.61M derived: sum of 3 quarters · filed 2022-08-09 | -$6.41M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$9.63M 10-Q · filed 2022-05-10 | -$7.30M derived: sum of 2 quarters · filed 2022-05-10 | $896.00K derived: sum of 3 quarters · filed 2022-05-10 | -$2.33M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $10.53M derived: sum of 2 quarters · filed 2022-03-11 | $7.30M derived: sum of 3 quarters · filed 2022-03-11 | $4.13M 10-K · filed 2022-03-11 |
| 2020-09-30 | $8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.97M derived: sum of 2 quarters · filed 2021-11-04 | $1.80M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$6.40M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | -$3.17M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |